REINSURANCE

12 Months Ended

Dec. 31, 2022

The Company periodically enters into fixed quota-share coinsurance agreements in the normal course of business. For each of its reinsurance agreements, the Company determines whether the agreement provides indemnification against loss or liability relating to insurance risk in accordance with applicable accounting standards. Reinsurance premiums and benefits paid or provided are accounted for on bases consistent with those used in accounting for the original policies issued and the terms of the reinsurance contracts. Premiums and benefits are reported net of insurance ceded.

The Company has recorded a deferred profit liability related to reinsurance transactions. The remaining deferred profit liability of $692 million and $859 million as of December 31, 2022 and 2021, respectively, is included in future policy benefits in the consolidated balance sheet and is being amortized into income over the expected lives of the policies. The Company has also recorded a reinsurance recoverable for reinsurance transactions, which is included in other assets in the consolidated balance sheet and had a remaining balance of $846 million and $957 million as of December 31, 2022 and 2021, respectively. The spot yen/dollar exchange rate weakened by approximately 13.3% and ceded reserves decreased approximately 11.7% from December 31, 2021 to December 31, 2022.

The following table reconciles direct premiums and direct benefits and claims to net amounts after the effect of reinsurance which also includes the elimination of inter-segment amounts associated with affiliated reinsurance for the years ended December 31.


(In millions)	2022			2021			2020
Direct earned premiums		$	15,387		$	17,857		$	18,955
Ceded to other companies:
Ceded Aflac Japan closed blocks		(343)			(431)			(466)
Other		(76)			(73)			(87)
Assumed from other companies:
Retrocession activities		144			180			195
Other		151			114			25
Net earned premiums		$	15,263		$	17,647		$	18,622

Direct benefits and claims		$	9,255		$	10,716		$	12,080
Ceded benefits and change in reserves for future benefits:
Ceded Aflac Japan closed blocks		(340)			(379)			(419)
Eliminations		23			31			39
Other		(38)			(36)			(63)
Assumed from other companies:
Retrocession activities		145			165			180
Eliminations		(23)			(31)			(39)
Other		131			110			18
Benefits and claims, net		$	9,153		$	10,576		$	11,796

These reinsurance transactions are indemnity reinsurance that do not relieve the Company from its obligations to policyholders. In the event that the reinsurer is unable to meet their obligations, the Company remains liable for the reinsured claims.

As a part of its capital contingency plan, the Company entered into a committed reinsurance facility agreement on December 1, 2015, with reserves of approximately ¥120 billion as of December 31, 2022. This reinsurance facility agreement was renewed in 2022 and is effective until December 31, 2023. There are also additional commitment periods of a one-year duration each of which are automatically extended unless notification is received from the reinsurer within 60 days prior to the expiration. The reinsurer can withdraw from the committed facility if Aflac‘s Standard and Poor's (S&P) rating drops below BBB-. As of December 31, 2022, the Company had not executed a reinsurance treaty under this committed reinsurance facility.